• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新出现的酵母病原体的初步鉴定:都柏林念珠菌(新种)可使氯化三苯四氮唑还原。

Presumptive identification of an emerging yeast pathogen: Candida dubliniensis (sp. nov.) reduces 2,3,5-triphenyltetrazolium chloride.

作者信息

Velegraki A, Logotheti M

机构信息

Department of Microbiology, Medical School, University of Athens, Goudi, Greece.

出版信息

FEMS Immunol Med Microbiol. 1998 Mar;20(3):239-41. doi: 10.1111/j.1574-695X.1998.tb01132.x.

DOI:10.1111/j.1574-695X.1998.tb01132.x
PMID:9566495
Abstract

Developments in medical intervention and the increasing population of patients with immunodeficiencies and transient or long-term immunosuppression have increased the list of yeast species that can cause disease. Candida dubliniensis is a novel species with close genetic relatedness to C. albicans. The two species share many common physiological and biochemical properties thus making their distinction cumbrous. A rapid and inexpensive way to presumptively differentiate between the two species, having previously performed a germ tube test, is the ability of C. dubliniensis to reduce the tetrazolium salt and it is reported for the first time. Microbiological information about new and emerging yeast pathogens, including rapid means for their identification, equips medical microbiologists with the means to identify and physicians to treat effectively infections attributed to unusual yeasts.

摘要

医学干预的发展以及免疫缺陷患者和短暂或长期免疫抑制患者数量的增加,使得可导致疾病的酵母种类增多。都柏林念珠菌是一种与白色念珠菌有密切遗传关系的新物种。这两个物种具有许多共同的生理和生化特性,因此区分它们很麻烦。在之前进行芽管试验后,一种快速且廉价的初步区分这两个物种的方法是都柏林念珠菌还原四氮唑盐的能力,这是首次报道。关于新型和新兴酵母病原体的微生物学信息,包括其快速鉴定方法,为医学微生物学家提供了识别手段,也为医生有效治疗由不常见酵母引起的感染提供了方法。

相似文献

1
Presumptive identification of an emerging yeast pathogen: Candida dubliniensis (sp. nov.) reduces 2,3,5-triphenyltetrazolium chloride.一种新出现的酵母病原体的初步鉴定:都柏林念珠菌(新种)可使氯化三苯四氮唑还原。
FEMS Immunol Med Microbiol. 1998 Mar;20(3):239-41. doi: 10.1111/j.1574-695X.1998.tb01132.x.
2
Tobacco agar, a new medium for differentiating Candida dubliniensis from Candida albicans.烟草琼脂,一种用于区分都柏林念珠菌和白色念珠菌的新培养基。
J Clin Microbiol. 2004 Oct;42(10):4796-8. doi: 10.1128/JCM.42.10.4796-4798.2004.
3
Evaluation of a rapid immunochromatographic assay for identification of Candida albicans and Candida dubliniensis.用于鉴定白色念珠菌和都柏林念珠菌的快速免疫层析检测法的评估
J Clin Microbiol. 2004 Nov;42(11):4956-60. doi: 10.1128/JCM.42.11.4956-4960.2004.
4
Candida dubliniensis and Candida albicans differentiation by colony morphotype in Sabouraud-triphenyltetrazolium agar.
Rev Iberoam Micol. 2015 Apr-Jun;32(2):126-8. doi: 10.1016/j.riam.2014.02.002. Epub 2014 Aug 29.
5
Candida albicans or Candida dubliniensis?白色念珠菌还是都柏林念珠菌?
Mycoses. 2011 Jan;54(1):1-16. doi: 10.1111/j.1439-0507.2009.01759.x.
6
Identification of Candida dubliniensis in a diagnostic microbiology laboratory.诊断微生物学实验室中都柏林念珠菌的鉴定
East Mediterr Health J. 2005 May;11(3):366-71.
7
Rapid differentiation of Candida dubliniensis from Candida albicans by early D-xylose assimilation.早期 D-木糖同化可快速区分杜氏念珠菌和白念珠菌。
Med Princ Pract. 2012;21(4):375-8. doi: 10.1159/000336586. Epub 2012 Mar 3.
8
Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans.区分都柏林念珠菌和白色念珠菌的简单、廉价、可靠方法。
J Clin Microbiol. 1998 Jul;36(7):2093-5. doi: 10.1128/JCM.36.7.2093-2095.1998.
9
A rapid screening test to distinguish between Candida albicans and Candida dubliniensis using NMR spectroscopy.
FEMS Microbiol Lett. 2005 Oct 15;251(2):327-32. doi: 10.1016/j.femsle.2005.08.016.
10
Prospective evaluation of the chromogenic medium CandiSelect 4 for differentiation and presumptive identification of non-Candida albicans Candida species.用于非白念珠菌属念珠菌种的鉴别及初步鉴定的显色培养基CandiSelect 4的前瞻性评估
Fungal Biol. 2016 Feb;120(2):173-8. doi: 10.1016/j.funbio.2015.09.006. Epub 2015 Sep 30.

引用本文的文献

1
Surfactants' Interplay with Biofilm Development in and .表面活性剂与[具体环境1]和[具体环境2]中生物膜形成的相互作用 。 (你提供的原文中“in and.”表述不完整,推测是这种补全后的翻译,具体需根据实际完整内容调整)
Pharmaceutics. 2024 May 15;16(5):657. doi: 10.3390/pharmaceutics16050657.
2
Candida dubliniensis: epidemiology and phenotypic methods for identification.都柏林念珠菌:流行病学和表型鉴定方法。
Mycopathologia. 2010 Jun;169(6):431-43. doi: 10.1007/s11046-010-9286-5. Epub 2010 Feb 21.
3
Amplification of the hyphal wall protein 1 gene to distinguish Candida albicans from Candida dubliniensis.
扩增菌丝壁蛋白1基因以区分白念珠菌和都柏林念珠菌。
J Clin Microbiol. 2006 Jul;44(7):2590-2. doi: 10.1128/JCM.00125-06.
4
Development and evaluation of a rapid latex agglutination test using a monoclonal antibody to identify Candida dubliniensis colonies.使用单克隆抗体鉴定都柏林念珠菌菌落的快速乳胶凝集试验的开发与评估。
J Clin Microbiol. 2006 Jan;44(1):138-42. doi: 10.1128/JCM.44.1.138-142.2006.
5
Evaluation of a rapid immunochromatographic assay for identification of Candida albicans and Candida dubliniensis.用于鉴定白色念珠菌和都柏林念珠菌的快速免疫层析检测法的评估
J Clin Microbiol. 2004 Nov;42(11):4956-60. doi: 10.1128/JCM.42.11.4956-4960.2004.
6
Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals.在来自人类免疫缺陷病毒(HIV)感染和未感染个体的白色念珠菌临床实验室分离株中对都柏林念珠菌分离株进行回顾性鉴定和特征分析。
J Clin Microbiol. 2000 Jun;38(6):2423-6. doi: 10.1128/JCM.38.6.2423-2426.2000.
7
Evaluation of phenotypic markers for selection and identification of Candida dubliniensis.用于选择和鉴定都柏林念珠菌的表型标记物评估。
J Clin Microbiol. 2000 Apr;38(4):1599-608. doi: 10.1128/JCM.38.4.1599-1608.2000.
8
Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel.从以色列非人类免疫缺陷病毒感染患者中分离出都柏林念珠菌。
J Clin Microbiol. 2000 Jan;38(1):170-4. doi: 10.1128/JCM.38.1.170-174.2000.
9
New monoclonal antibody specific for Candida albicans germ tube.新型抗白色念珠菌芽管特异性单克隆抗体。
J Clin Microbiol. 2000 Jan;38(1):61-7. doi: 10.1128/JCM.38.1.61-67.2000.